
Professor and Regional Chair of Pathology and Laboratory Medicine @CleveClinicFL
Chicago, IL
Joined March 2020
- Tweets499
- Following312
- Followers976
- Likes1.7K
Looking for a clinical research fellow with interest in #hemepath.
Amir Behdad retweeted
New! "Recommendations for Next-Generation Sequencing Germline Variant Confirmation: A Joint Report of @AMPath and @GeneticCouns" is now available FREE online ahead of publication in @JMDiagn: ow.ly/BzP250OrkaV #molpath #NGS #genetictesting
Amir Behdad retweeted
What happens after a #stroke? 🧠
Neurologist, @AmreNouh addresses this common concern and more.
Learn more about our Department of Neurosciences: cle.clinic/3Kjt9RI #StrokeAwarenessMonth
Amir Behdad retweeted
A new @AMPath/@GeneticCouns report provides recommendations for orthogonal confirmation practices designed to promote #NGS sequencing germline variant confirmation standardization, transparency & quality improvement among laboratories. Learn more: ow.ly/BzP250OrkaV #molpath
Sometimes just the touch preps are enough for the diagnosis! #hemepath @CleveClinicFL @CLEClinicLabs
Thank you @JoakimNoah, my son Lucas was over the moon! And yes @cpr4pain we would have loved to see him get on the floor 😂
Amir Behdad retweeted
Loved reconnecting with our #PurplePath family at our alumni reception at #USCAP2023! So many familiar faces and great memories shared. @TheUSCAP
I am thrilled to join a team of superstar caregivers and leaders @CleveClinicFL and @CleClinicNews! Extremely grateful to @NU_Pathology for an amazing 8.5 years.
We're excited to introduce Amir Behdad, MD, MBA, as Regional Institute Chair, Department of Pathology & Laboratory Medicine, and Department Chair of Pathology & Laboratory Medicine at Weston Hospital.
Learn more about @AmirBehdadMD here: cle.clinic/3LbwvcU
Amir Behdad retweeted
(1/2) Please join us in an educational event to mark the retirement of Dr. Steve Swerdlow
===> Monday 11/14, 11am-5:15pm EST <===
*Link to join on Microsoft Teams:
tinyurl.com/3c4yamxb
Amir Behdad retweeted
ICCS plenary session 2 starts with a CSI case of T-ALL with SET::NUP214 with aberrant CD19 and cCD79a expression, don’t call MPAL!! In our experience, around 10-20% TALL can have aberrant CD19 expression, do PAX5 #flowiccs2022
Amir Behdad retweeted
#ArticleinPress: Validation Study of a Direct Real-Time PCR Protocol for Detection of #Monkeypox Virus. New from @AMPath member Dr. Lawrence Jennings and coauthors from @NU_Pathology and @NUFeinbergMed.
FREE to access: jmdjournal.org/article/S1525…
Amir Behdad retweeted
Pathology residents: come visit @NU_Pathology at the @ASCP_Chicago fellowship fair and learn more about all the fellowships we have to offer. #ASCP100 #ASCP2022 #PurplePath #PathTwitter
Amir Behdad retweeted
Learn from #molpath experts including @AlannaChurch_MD, @adamsfisch, @DrMarjorieDavid, @AmirBehdadMD, @J_Kleinberger & more at "Get AMPed! Case Studies in Molecular #Pathology". Sign up by 9/15 to save on registration for the course and #AMPath22! ow.ly/nBxT50KlWuV
AML with GATA2::MECOM rearrangement [inv(3)], and PTPN11 mutation. Dysplasia and RAS pathway mutations are common. Both #WHO and #ICC recognize cases with <20% blasts as AML (ICC>=10%). #PathTwitter #hemepath @NU_Pathology
Asking @jaltmanmd and @yasminabaza1 if blast count of 10-20 and >20 has any bearing in their treatment strategy for this entity
Amir Behdad retweeted
Learn from #molpath experts including @AlannaChurch_MD, @adamsfisch, @DrMarjorieDavid, @AmirBehdadMD, @J_Kleinberger at "Get AMPed! Case Studies in Molecular Pathology" - this November 2nd in Phoenix, AZ (before #AMPath22). Register today! ow.ly/nBxT50KlWuV






























